The FDA’s Neurological Devices Advisory Panel has recommended approval of the Pipeline device for “endovascular treatment of large or giant wide-necked intracranial aneurysms in the cavernous and paraclinoid regions of the internal carotid artery.” The product, made by ev3, a Plymouth, MN company recently acquired by Covidien, already has EU’s CE Mark of approval.
Flow Re-Direction
• 85% reduction in circulation within aneursym
• 3-5 fold increase in surface coverage compared to intracranial stents
Treat in Difficult Anatomy
• Flexibility allows it to be delivered and used in tortuous anatomy
Treat Thin Walled Aneurysms
• Because PED is not an intrasaccular therapy, you can treat even thin walled aneurysms
Custom Coverage
• The ability to place multiple devices, one inside another allows customized constructs with variable degrees of aneurysm coverage and flow disruption
Branch Vessel Preservation
• Optimized surface coverage ratio provides flow diversion from the aneurysm but preserves flow in perforators or branch vessels
Endothelial Re-Pavement
• Bimetallic microfabricate braid provides a flexible yet supportive structure across the aneurysm neck
• Scaffolding promotes endothelial re-pavement, excluding the aneurysm from circulation
Press release: Covidien Announces FDA Advisory Committee Unanimously Recommends Approval for Pipeline(TM) Embolization Device…
Product page: Pipeline Embolization Device…